Envirocleanse, LLC, owned by Charter Brokerage – a BERKSHIRE HATHAWAY company – has developed its inTank Ballast Water Treatment System (BWTS), in collaboration with Glosten, Inc., to prevent the transfer of harmful aquatic species via ship’s ballast water. With patented nozzles inside the ballast tanks and a robust hypochlorite generator, the Envirocleanse inTankTM BWTS is the most advanced and sustainable system on the market.
The inTankTM BWTS process ensures disinfection of ballast water tanks and piping through the application of a targeted CT, which is the product of disinfection Concentration (in milligrams per liter, mg/L) and disinfection contact Time (in hours) measured as total residual oxidant (TRO). The system works by circulating each ballast tank, injecting disinfectant, until the target dose is reached. This is all done while the vessel is underway, thus eliminating the risk of interrupting port operations.
The Envirocleanse mission is to provide the world with a sustainable biocide. The patent-pending technology behind Envirocleanse was brought to the forefront by Dr. Phil Bellan as a means to fight infection in wounds. In late 2015, Charter Brokerage, a BERKSHIRE HATHAWAY unit, bought Envirocleanse to increase Envirocleanse’s size and scope. Since its purchase, the company has begun to expand into the oil-and-gas, medical, food and food distribution, and the ballast-water-treatment industries. The flagship of Envirocleanse is the FDA-approved and EPA-registered disinfectant known as Envirocleanse-A (the A stands for “Anolite”). The Anolite solution is hypochlorous acid (HOCL), a nontoxic, non-corrosive biodegradable disinfectant. Envirocleanse has teamed up with Glosten Marine Engineering to create the only In-Tank Ballast Water Treatment System (BWTS) on the market. Treating the water in the tank provides numerous advantages over all other BWTS currently available. To find out more, please contact one of our listed team members.